Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin

Infectious Diseases and Therapy

Volumn 2, Issue 2, 2013, Pages 201-208

  Carreno, Joseph J ^a,b   Jaworski, Anthony ^a,b   Kenney, Rachel M ^a,b   Davis, Susan L ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Acute kidney injury; Aged; Drug toxicity; Elderly; Infectious diseases; Nephrotoxicity; Vancomycin

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B; COLISTIN; DOPAMINE; NORADRENALIN; PHENYLEPHRINE; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; AGING; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CREATININE CLEARANCE; DRUG MEGADOSE; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROTOXICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84977090450     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-013-0022-6     Document Type: Article

References (20)

1. Farber BF, Moellering RC Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother. 1983;23: 138-41.
2. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52: 1330-6.
3. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009;49: 507-14.
4. Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: we can't get there from here. Clin Infect Dis. 2011;52: 969-74.
5. Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther. 2007;29: 1107-15.
6. Cano EL, Haque NZ, Welch VL, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther. 2012;34: 149-57.
7. Vance-Bryan K, Rotschafer JC, Gilliland SS, Rodvold KA, Fitzgerald CM, Guay DR. A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient. J Antimicrob Chemother. 1994;33: 811-21.
8. Minejima E, Choi J, Beringer P, Lou M, Tse E, Wong-Beringer A. Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients. Antimicrob Agents Chemother. 2011;55: 3278-83.
9. Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011;55: 5475-9.
10. Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother. 1990;25: 679-87.
11. Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42(Suppl 1): S5-12.
12. United Nations. World Population Ageing: 1950-2050 Executive Summary [Webpage]. Internet: United Nations; 2002. Available from: http://www. un. org/esa/population/publications/worldageing19502050/pdf/62executivesummary_english. pdf. Accessed 10 June 2013.
13. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Statist Rep. 2013;61: 1-55.
14. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007;13: 1840-6.
15. Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49: 325-7.
16. Pauly DJ, Musa DM, Lestico MR, Lindstrom MJ, Hetsko CM. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy. Pharmacotherapy. 1990;10: 378-82.
17. Lodise TP, Drusano GL, Butterfield JM, Scoville J, Gotfried M, Rodvold KA. Penetration of vancomycin into epithelial lining fluid in healthy volunteers. Antimicrob Agents Chemother. 2011;55: 5507-11.
18. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171: 388-416.
19. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52: e18-55.
20. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol. 2011;22: 999-1006.